-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2010 to Q1 2025.
- Cyclacel Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2025 was $4K.
- Cyclacel Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2018 was $331K, a 181% increase from 2017.
- Cyclacel Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2017 was $118K.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)